Malformations in a cohort of 284 women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) by Patricia G Oppelt et al.
Oppelt et al. Reproductive Biology and Endocrinology 2012, 10:57
http://www.rbej.com/content/10/1/57RESEARCH Open AccessMalformations in a cohort of 284 women
with Mayer-Rokitansky-Küster-Hauser
syndrome (MRKH)
Patricia G Oppelt1†, Johannes Lermann1†, Reiner Strick1, Ralf Dittrich1, Pamela Strissel1, Ingo Rettig2,
Christine Schulze1, Stefan P Renner1, Matthias W Beckmann1, Sara Brucker3, Katharina Rall3† and Andreas Mueller1*†Abstract
Background: The aim of this retrospective study was to describe the spectrum of genital and associated
malformations in women with Mayer-Rokitansky-Küster-Hauser syndrome using evaluated diagnostic procedures
and the Vagina Cervix Uterus Adnex – associated Malformation classification system (VCUAM).
Methods: 290 women with MRKH syndrome were clinically evaluated with using clinical examinations, abdominal
and perineal/rectal ultrasound, MRI, and laparoscopy.
Results: Classification of female genital malformation according to the Vagina Cervix Uterus Adnex – associated
Malformation classification system was possible in 284 women (97.9%). Complete atresia of Vagina (V5b) and
bilateral atresia of Cervix (C2b) were found in 284 patients (100%). Uterus: bilateral rudimentary or a plastic uterine
horns were found in 239 women (84.2%). Adnexa: normal Adnexa were found in 248 women (87.3%).
Malformations: associated malformations were found in 126 of 282 evaluable women (44.7%), 84 women (29.6%)
had malformations of the renal system. Of 284 women with Mayer-Rokitansky-Küster-Hauser syndrome 212 women
(74.7%) could be classified as V5bC2bU4bA0. The most frequent classification was V5bC2bU4bA0M0 (46.8%)
diagnosed in 133 of 284 women.
Conclusions: Complete atresia of vagina and cervix were found in all patients, variable malformations were found
with uterus and adnexa. A variety of associated malformations were present, predominantly of the renal system. It is
therefore recommended that all patients with genital malformations should be evaluated for renal abnormalities.
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The Mayer–Rokitansky–Küster–Hauser (MRKH) syn-
drome describes women with normal female external de-
velopment and internally with normally regressed
mesonephric (Wolffian) ducts, but abnormally absent
paramesonephric (Müllerian) ducts. MRKH syndrome
involves congenital aplasia of the uterus, cervix and upper
two-thirds of the vagina. The syndrome is only revealed
when primary amenorrhea is noticed or attempts at coitus
are in vain. It occurs as a purely genital malformation* Correspondence: andreas.mueller@uk-erlangen.de
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reproduction in any medium, provided the or(type 1), but also with associated malformations (type 2
and MURCS association; Müllerian renal, cervicothoracic
somite abnormalities) [1]. Malformations of the kidneys
and urinary tract the skeleton, and more rarely of the
heart and central nervous system have been described [2].
The incidence of the syndrome is one in 4,500 female
newborns [1]. A failure of fusion of Müllerian duct deriva-
tives during gestational weeks 4–12 results in malforma-
tion of the vagina and uterus [3]. However, the precise
pathogenetic mechanism is still unknown. MRKH patients
have a correctly timed pubarche and thelarche and have a
normal female karyotype (46, XX) [3]. The syndrome was
first described by Mayer [4] in 1829, and Rokitansky [5]
later published a case report on similar malformations. In
1910, Küster wrote the first review on the syndrome [6].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 VCUAM classification [8]
Organ Stage Description
Vagina (V) 0 Normal
1a Partial hymenal atresia
1b Complete hymenal atresia
2a Incomplete septate vagina < 50%
2b Complete septate vagina




S1 Sinus urogenitalis (deep confluence)
S2 Sinus urogenitalis (middle confluence)










Uterus (U) 0 Normal
1a Arcuate
1b Septate <50% of the uterine cavity
1c Septate >50% of the uterine cavity
2 Bicornate
3 Hypoplastic uterus
4a Unilaterally rudimentary or aplastic
4b Bilaterally rudimentary or aplastic
+ Other
# Unknown
Adnexa (A) 0 Normal
1a Unilateral tubal malformation, ovaries
normal
1b Bilateral tubal malformation, ovaries
normal
2a Unilateral hypoplasia/gonadal streak
(includingtubal malformation if
appropriate)
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http://www.rbej.com/content/10/1/57Hauser and Schreiner were the first in 1961 to call it
Mayer–Küster–Rokitansky syndrome [7]. The final
addition of Hauser to the name resulted in today’s term,
Mayer–Rokitansky–Küster–Hauser syndrome.
The Vagina, Cervix, Uterus, Adnex – associated Mal-
formation (VCUAM) classification (Table 1) was intro-
duced in 2005 to allow an accurate description of genital
and associated malformations [8-11].
Clinical examination, ultrasound, magnetic resonance
imaging (MRI), and laparoscopy can help to diagnose
MRKH syndrome [9,12-16]. We recently presented a
comparison of different diagnostic procedures for the
correct staging of the malformations according to the
VCUAM classification with defined reference methods
for the different organs involved in the syndrome. The
reference methods were: vagina — clinical examination;
cervix/uterus and adnexa — laparoscopy; urinary tract
malformations — MRI [17]. The quality of other diag-
nostic procedures for each organ was expressed as
agreement with the reference methods, which was pre-
sented as kappa value (k). For vagina and cervix only
clinical examination was found to be sufficient , for
uterus MRI (k 0.93) or ultrasound (k 0.83) were found to
be sufficient, for adnexa only laparoscopy was found to
be sufficient and for urinary tract malformations ultra-
sound was also found to be sufficient (k 0.87) [17].
The aim of this study was to describe the spectrum of
malformations in a large cohort of 290 women with
MRKH syndrome in order to verify the most common
subtypes of this syndrome.
Methods
The study is a two centre retrospective analysis of 290
women who were treated between January 2000 and
October 2011 for MRKH syndrome in the University
hospitals of Erlangen and Tübingen (Germany).
All patient files were systematically analysed and all
data were used anonymously. Each malformation of the
organs was classified in accordance with the VCUAM
classification [8,9], based upon the results of the refer-
ence methods, for vagina — clinical examination, for
cervix and adnexa — laparoscopy for uterus – ultra-
sound and for associated malformations — MRI. In case
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reference methods other diagnostic procedures with a
good agreement with the reference methods (k > 0.80)
were considered. Vagina: all women received a regular
gynecological examination, including rectal palpation.
Uterus: ultrasound examinations were performed trans-
abdominally using standard 2–7 MHz probes, or perine-
ally/transrectally using standard 3.3–10 MHz probes in
all women. Cervix and adnexa: all women underwent
laparoscopy, sometimes as part of a modified laparo-
scopic Vecchietti operation [18-20]. Malformations:
Ultrasound examinations were performed transabdomin-
ally using standard 2–7 MHz probes and/or MRI was
carried out with a 1.5-T magnetic resonance system in
some women. Approval for conducting basic research
and compiling the relevant documentation to perform
this study was received through Institution review board
(IRB) approval No. 3074.Statistical analysis
All data are presented as frequencies and percentages
using Microsoft Office Excel 2009 and IBM SPSS
Statistics 19.Results
The patient files of 290 women with MRKH syndrome
who were diagnosed and treated during the study period
were analysed and 284 files were eligible for inclusion in
the analysis. Six patient files were excluded because of
missing examination results. All 284 women underwent
clinical examination, ultrasound and laparoscopy. A
diagnostic laparoscopy and/or therapeutic intervention
were performed with 275 women (96.8%). MRI of the
urinary tract was carried out in most women; in addition
an MRI was performed for some women to investigate
skeletal malformations. Women with skeletal, neuronal
or cardiac malformations were further examined, using
thorax X-ray, echocardiography, audiometry or visual
tests. The mean age of the women at the time of inclu-
sion was 26.2 (SD 8.8) years and the mean body mass
index at the time of diagnostic or therapeutic interven-
tion was 23.1 (SD 4.8) kg/m2.VCUAM classifications
Vagina (V)
284 women (100%) showed stage V5b (complete atresia)
of the vagina.Cervix (C)
284 women (100%) showed stage 2b (bilateral atresia/
aplasia).Uterus (U)
239 women (84.2%) showed stage 4b (bilateral rudimen-
tary or aplastic), 27 women (9.5%) showed stage 4a (uni-
lateral rudimentary or aplastic), eight women (2.8%)
showed other and eight women (2.8%) were not classifi-
able. Two women (0.7%) showed stage 3 (hypoplastic
uterus).
Adnexa (A)
248 women (87.3%) showed stage 0 (normal adnexa),
nine (3.2%) were not classifiable, ten (3.5%) showed stage
2a (unilateral hypoplasia), seven (2.5%) showed 1b (bilat-
eral tubal malformation) and six women (2.1%) showed
stage 3a (unilateral aplasia). Two women (0.7%) showed
stage 2b (bilateral hypoplasia/gonadal streak) and one
women (0.4%) stage 1a (unilateral tubal malformation).
One woman (0.4%) showed other malformations.
Malformations (M)
In 156 women (54.9%) of 284 women no associated mal-
formations were diagnosed (stage 0). In 53 women
(18.7%) malformations of the renal system (stage R) and
in 22 women (7.7%) malformations of the skeleton (stage
S) were found. Two women (0.7%) were not classifiable,
five (1.8%) showed other malformations, two women
(0.7%) showed cardiac malformations and four woman
(1.4%) showed neurologic malformations. Moreover in
38 women (13.4%) different combinations (renal, skel-
eton, cardiac, neurologic, others) were found. Table 2
illustrates associated malformations of 282 women, ex-
cluding two women which were not classifiable. Eighty-
four patients (29.6%) showed renal malformations where
two women were excluded because of an unknown renal
status (see Table 3). Fifty-three of these 84 patients
(64.4%) or 18.8% of all patients with known malforma-
tions showed a renal agenesis.
In summary, excluding associated malformations from
284 women with MRKH syndrome, 212 women could
be classified as complete atresia of the vagina (V5b), bi-
lateral atresia of the cervix (C2b), bilateral aplastic
uterus (U4b) and normal adnexa (A0) (74.7%). The most
frequent VCUAM classification was V5bC2bU4bA0M0
diagnosed in 133 (46.8%) of 284 women. The spectrum
of associated malformations is shown in Figure 1.
Discussion
To the best of our knowledge, this study represents the
largest cohort of 284 women with MRKH syndrome
diagnosed with evaluated and standardized diagnostic
procedures and grouped according to a defined classifi-
cation system. There is a unique occurrence in malfor-
mations of the distal genital system; vagina, cervix and
uterus. The spectrum of variations accumulates in the
more proximal part of the female genital system with a
Table 2 VCUAM classification of 284 patients with MRKH syndrome
Vagina n (%) Cervix n (%) Uterus n (%) Adnexa n (%) Malformation n (%)
V5b 284 (100%) C2b 284 (100%) U0 0 (0%) A0 248 (87.3%) M0 156 (54.9%)
U1a 0 (0%) A1a 1 (0.4%) MR 53 (18.7%)
U1b 0 (0%) A1b 7 (2.5%) MS 22 (7.7%)
U1c 0 (0%) A2a 10 (3.5%) MC 2 (0.7%)
U2 0 (0%) A2b 2 (0.7%) MN 4 (1.4%)
U3 2 (0.7%) A3a 6 (2.1%) M+ 5 (1.8%)
U4a 27 (9.5%) A3b 0 (0%) M# 2 (0.7%)
U4b 239 (84.2%) A+ 1 (0.4%) Combinations
U+ 8 (2.8%) A# 9 (3.2%) MR+ 3 (1.1%)












Table 3 Specification of 82 renal malformations






pelvic kidney + ureter malformation 1
double renal pelvis 1
duplex kidney 5
duplex kidneys 1
duplex kidney + ureter malformation 1
cirrhosis of the kidney 3
horseshoe kidney 3
horseshoe kidney + ureter malformation + cystic kidney disease 1
kidney agenesis 35
kidney agenesis + duplex ureter 1
kidney agenesis + pelvic kidney 15
kidney agenesis + pelvic kidney + renal malrotation 1
kidney agenesis + bladder malformation + persistent urachus 1
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associated malformations were found in the renal system
along with additional numerous combinations of differ-
ent malformations (see Figure 1).
Examination of women with MRKH syndrome
revealed according to the definition of MRKH syndrome
an absence or severe hypoplasia of the upper vagina as
well as uterine agenesis. In the present study 100% of
MRKH women showed a complete atresia of vagina, al-
though 1–3 cm of the lower vagina can be present. We
found in 100% of patients an aplasia of the cervix
(Table 2). In our study 87.3% of patients showed normal
adnexa (stage A0), ten (3.5%) showed stage 2a (unilateral
hypoplasia), seven (2.5%) showed 1b (bilateral tubal mal-
formation) and six women (2.1%) showed stage 3a (uni-
lateral aplasia). Two women (0.7%) showed stage 2b
(bilateral hypoplasia/gonadal streak) and one women
(0.4%) stage 1a (unilateral tubal malformation). One
woman (0.4%) showed other malformations (Table 2).
We did not find a tendency toward polycystic ovaries
as some authors reported [7,21,22]. We agree with
Rokitansky, Bompiani and Oppelt et al. who described
hypoplastic or aplastic ovaries only in a few cases
[3,5,23]. Characteristic for all MRKH patients is the uni-
lateral or bilateral hypoplasia of the uterus. In our study
84.2% showed bilaterally rudimentary or aplastic uterus,
Figure 1 Malformations of 282 patients with MRKH syndrom excluding M#. M+= 5, M0= 156, MC= 2, MC+= 1, MN= 4, MR= 53, MR+= 3,
MRC= 1, MRC+= 1, MRN= 2, MRS = 15, MRS+= 4, MRSC= 2, MRSN= 3, MS = 22, MS += 2, MSC= 1, MSCN= 2; MSN= 3.
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http://www.rbej.com/content/10/1/57in 9.5% a unilaterally rudimentary or aplastic uterus
was diagnosed. Two (0.7%) women had a hypoplastic
uterus (Table 2). These proportions of the uterus develop-
mental state in MRKH patients was similar to Guerrier
et al. [24].
The present analysis showed that 44.4% of the patients
were affected by associated malformations. Excluding
women which were not classifiable (M#) (0.7%), we
found associated malformations in 44.7% of patients
(Table 3). The rate of associated malformations in
patients with MRKH syndrome reported in the literature
was between 53% [3] and 64% [25]. Although MRKH
patients have a normal female karyotype, in case of se-
vere hormonal alterations, like the androgen insensitivity
syndrome, it is recommended that patients should be
analysed for chromosomal changes. In our study we fo-
cused more on the examination of the renal system,
where every woman received an examination by laparos-
copy and ultrasound and/or MRI. No direct symptoms
of skeletal malformations like dorsal pain, scoliosis etc.
excluded MRI analysis. An open inguinal canal was often
found during laparoscopy, but only women with an
operated inguinal hernia were classified as M+. Malfor-
mations of the renal system were seen in up to 32% of
the patients and represented the largest proportion of
affected organs [3]. 29.6% of our cohort (284 patients)
had renal malformations, confirming this as the most
frequent associated malformation with MRKH (Table 3).
The most frequent renal malformation was a renal agen-
esis (64.4%).
Furthermore, we support that the associated renal
malformations with MRKH can be explained due to theclose link between genital and urinary embryonal
development.
The human genital tracts are undifferentiated until the
8th week of gestation and are referred to as “bipotential
or indifferent” gonads. At this time both the male and
female embryo have two symmetrical paired genital
ducts: the mesonephric (Wolffian) and the parameso-
nephric (Müllerian) ducts, which originate from the
intermediate mesoderm. Together with the urogenital
sinus they provide the bases for internal and external
genital development. Only one of the two ductal systems
will normally develop further, depending on whether dif-
ferentiation of a testis or ovary has begun. The distal
mesonephric duct is the starting point for a pair of ur-
eteric buds, which grow into the cloaca and induces the
overlying metanephros to develop into the primitive kid-
neys. The ureteric buds and distal portions of the meso-
nephric ducts are later incorporated into the wall of the
primitive bladder to develop into ureters, trigone and
bladder neck. In the female embryo, the mesonephric
duct regresses completely and the paramesonephric
(Müllerian) duct develops into the fallopian tubes,
uterus, cervix and upper part of the vagina. Importantly,
ovaries originate within the primitive ectoderm, thus are
independent of the mesonephros. In the male embryo,
testosterone and androstenedione stimulates mesoneph-
ric duct development to form the epididymi, vasa defer-
entia and seminal vesicles, while the Müllerian duct
regresses in response to anti-Müllerian-hormone, which
is secreted from the Sertoli cells. The disappearance of
the Müllerian ducts in the male fetus is completed by 9
to 10 weeks of gestation [26-28].
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urinary tract defects occur in as many as 1:100 live
births and constitute the most frequent cause of chronic
kidney disease in children [29]. Considering the inci-
dence of MRKH in ~1:4,500 live female births, congeni-
tal renal malformations (as well as unilateral renal
agenesis) in MRKH patients are higher compared to the
general population. This is not surprising due to the as-
sociation and interaction of the two ductal systems for
normal genital and renal development. Combined uro-
genital malformations are common with estimations of
10 in 100 cases and account for over 30% of all congeni-
tal malformations [30]. Malformations of the genital and
renal axis are common, e.g. 35% of females where unilat-
eral renal agenesis showed partial or complete duplica-
tion of the genital tract [31]; renal agenesis was present
in 43% of patients with uterus didelphys and 10% of
patients with other genital tract abnormalities had an ab-
normal or ectopic kidney [32]. As a matter of course all
patients with genital malformations should be evaluated
for renal abnormalities, may be patients with renal ab-
normalities should also be assessed for genital
malformations.
Conclusions
There is a unique occurrence in malformations of the
distal genital system; vagina, cervix and uterus, while the
spectrum of variations accumulates in the more prox-
imal part of the female genital system with a variety of
adnexal and associated malformations. Those malforma-
tions can be classified precisely using evaluated diagnos-
tic procedures and a standardized classification system.
It is recommended that all patients with genital malfor-
mations should be evaluated for renal abnormalities, but
importantly patients with renal abnormalities should
also be assessed for genital malformations.
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